Parallax Health Sciences Inc. announced earnings results for the full year ended December 31, 2018. For the full year, the company announced sales was USD 11,739 compared to USD 94,937 a year ago. Operating loss was USD 6.561 million compared to USD 4.044 million a year ago. Net income was USD 16.289 million compared to net loss of USD 13.664 million a year ago. Basic earnings per share from continuing operations was USD 0.115 compared to basic loss per share from continuing operations of USD 0.087 a year ago. Diluted earnings per share from continuing operations was USD 0.079 compared to diluted loss per share from continuing operations of USD 0.059 a year ago.